Pyroptotic death storms and cytopenia.

[1]  James L. Mueller,et al.  Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies. , 2013, The Journal of clinical investigation.

[2]  T. Eulgem,et al.  NSD1 Mitigates Caspase-1 Activation by Listeriolysin O in Macrophages , 2013, PloS one.

[3]  D. Powell,et al.  Cytoplasmic LPS Activates Caspase-11: Implications in TLR4-Independent Endotoxic Shock , 2013, Science.

[4]  M. T. Wong,et al.  Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4 , 2013, Science.

[5]  F. Shao,et al.  Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation , 2013, Proceedings of the National Academy of Sciences.

[6]  G. Núñez,et al.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. , 2013, Immunity.

[7]  B. Monks,et al.  Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis. , 2013, Nature chemical biology.

[8]  K. Schroder,et al.  AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC , 2013, Cell Death and Differentiation.

[9]  G. Núñez,et al.  The protein kinase PKR is critical for LPS‐induced iNOS production but dispensable for inflammasome activation in macrophages , 2013, European journal of immunology.

[10]  Chen Yang,et al.  Cellular localization of NLRP3 inflammasome , 2013, Protein & Cell.

[11]  R. Liddington,et al.  Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation , 2013, Proceedings of the National Academy of Sciences.

[12]  R. Germain,et al.  The Adaptor MAVS Promotes NLRP3 Mitochondrial Localization and Inflammasome Activation , 2013, Cell.

[13]  A. Strasser,et al.  Bcl‐2 overexpression ameliorates immune complex‐mediated arthritis by altering FcγRIIb expression and monocyte homeostasis , 2013, Journal of leukocyte biology.

[14]  P. Kovanen,et al.  Extracellular Acidosis Is a Novel Danger Signal Alerting Innate Immunity via the NLRP3 Inflammasome , 2013, The Journal of Biological Chemistry.

[15]  S. Akira,et al.  Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome , 2013, Nature Immunology.

[16]  Daniel E. Zak,et al.  Caspase-11 Protects Against Bacteria That Escape the Vacuole , 2013, Science.

[17]  F. Sutterwala,et al.  TRPM2 links oxidative stress to the NLRP3 inflammasome activation , 2013, Nature Communications.

[18]  Daniel R. Richards,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013, Proceedings of the National Academy of Sciences.

[19]  C. Alpuche-Aranda,et al.  This information is current as Activation and Cell Death Cells by Preventing Inflammasome Expression To Promote Its Survival in B Family CARD Domain Containing Protein 4 Downregulates Nod-like Receptor Salmonella , 2013 .

[20]  Junying Yuan,et al.  Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. , 2013, Molecular cell.

[21]  Andrew Kovalenko,et al.  Caspase-8 blocks kinase RIPK3-mediated activation of the NLRP3 inflammasome. , 2013, Immunity.

[22]  Yingwei Chen,et al.  Curcumin suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock. , 2013, Molecular nutrition & food research.

[23]  R. Flavell,et al.  Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophila , 2013, Proceedings of the National Academy of Sciences.

[24]  Lei Li,et al.  CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. , 2013, Blood.

[25]  K. J. Henley,et al.  NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells. , 2012, Immunity.

[26]  B. Cookson,et al.  The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing. , 2012, Cell host & microbe.

[27]  Hardy Kornfeld,et al.  Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome–dependent processing of IL-1β , 2012, Nature Immunology.

[28]  R. Germain,et al.  The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP , 2012, Nature.

[29]  F. Baas,et al.  Genetic variation in inflammasome genes is associated with outcome in bacterial meningitis , 2012, Immunogenetics.

[30]  G. López-Castejón,et al.  Cell volume regulation modulates NLRP3 inflammasome activation. , 2012, Immunity.

[31]  E. Alnemri,et al.  Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation* , 2012, The Journal of Biological Chemistry.

[32]  V. Dixit,et al.  Phosphorylation of NLRC4 is critical for inflammasome activation , 2012, Nature.

[33]  Christine E. Becker,et al.  TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by Gram-Negative Bacteria , 2012, Cell.

[34]  J. Bertin,et al.  The NLRP12 inflammasome recognizes Yersinia pestis. , 2012, Immunity.

[35]  Kamila Belhocine,et al.  Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1 , 2012, Nature.

[36]  M. Bogyo,et al.  Caspase-1 activity is required to bypass macrophage apoptosis upon Salmonella infection , 2012, Nature chemical biology.

[37]  K. Tracey,et al.  Novel role of PKR in inflammasome activation and HMGB1 release , 2012, Nature.

[38]  Jiujiu Yu,et al.  Critical role for calcium mobilization in activation of the NLRP3 inflammasome , 2012, Proceedings of the National Academy of Sciences.

[39]  J. Bertin,et al.  Autolytic Proteolysis within the Function to Find Domain (FIIND) Is Required for NLRP1 Inflammasome Activity* , 2012, The Journal of Biological Chemistry.

[40]  J. Tschopp,et al.  Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1. , 2012, Immunity.

[41]  Moshe Arditi,et al.  Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. , 2012, Immunity.

[42]  J. Tschopp,et al.  Inhibitor of apoptosis proteins limit RIP3 kinase-dependent interleukin-1 activation. , 2012, Immunity.

[43]  M. Rossol,et al.  Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors , 2012, Nature Communications.

[44]  M. Saleh,et al.  Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome. , 2011, Immunity.

[45]  R. Hotchkiss,et al.  Immunosuppression in patients who die of sepsis and multiple organ failure. , 2011, JAMA.

[46]  A. Godzik,et al.  CARD8 and NLRP1 Undergo Autoproteolytic Processing through a ZU5-Like Domain , 2011, PloS one.

[47]  Jinfeng Liu,et al.  Non-canonical inflammasome activation targets caspase-11 , 2011, Nature.

[48]  D. Monack,et al.  Elevated AIM2‐mediated pyroptosis triggered by hypercytotoxic Francisella mutant strains is attributed to increased intracellular bacteriolysis , 2011, Cellular microbiology.

[49]  Christopher L. Case,et al.  Asc Modulates the Function of NLRC4 in Response to Infection of Macrophages by Legionella pneumophila , 2011, mBio.

[50]  B. Kobe,et al.  Structural and functional analysis of a plant resistance protein TIR domain reveals interfaces for self-association, signaling, and autoregulation. , 2011, Cell host & microbe.

[51]  S. Crovella,et al.  The Missense Variation Q705K in CIAS1/NALP3/NLRP3 Gene and an NLRP1 Haplotype Are Associated With Celiac Disease , 2011, The American Journal of Gastroenterology.

[52]  S. Ryter,et al.  Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. , 2011, Nature immunology.

[53]  J. Tschopp,et al.  A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.

[54]  R. Vance,et al.  Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. , 2010, Cell host & microbe.

[55]  S. Leppla,et al.  Inflammasome Sensor Nlrp1b-Dependent Resistance to Anthrax Is Mediated by Caspase-1, IL-1 Signaling and Neutrophil Recruitment , 2010, PLoS pathogens.

[56]  B. Mougin,et al.  EARLY ASSESSMENT OF LEUKOCYTE ALTERATIONS AT DIAGNOSIS OF SEPTIC SHOCK , 2010, Shock.

[57]  Christine E. Becker,et al.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes , 2010, Nature Immunology.

[58]  A. Fischer,et al.  Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. , 2010, Blood.

[59]  V. Dixit,et al.  Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella , 2010, The Journal of experimental medicine.

[60]  A. Roberts,et al.  Regulation of interleukin‐1β by interferon‐γ is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin‐17 production , 2010, EMBO reports.

[61]  F. Sutterwala,et al.  A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. , 2010, Cell host & microbe.

[62]  A. Iwasaki,et al.  Influenza virus activates inflammasomes through intracellular M2 channel , 2010, Nature Immunology.

[63]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[64]  S. Smeekens,et al.  Reactive oxygen species–independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease , 2010, Proceedings of the National Academy of Sciences.

[65]  S. Welkos,et al.  Cutting Edge: Resistance to Bacillus anthracis Infection Mediated by a Lethal Toxin Sensitive Allele of Nalp1b/Nlrp1b , 2009, The Journal of Immunology.

[66]  J. Tschopp,et al.  Malarial Hemozoin Is a Nalp3 Inflammasome Activating Danger Signal , 2009, PloS one.

[67]  A. Zauberman,et al.  Yersinia pestis Endowed with Increased Cytotoxicity Is Avirulent in a Bubonic Plague Model and Induces Rapid Protection against Pneumonic Plague , 2009, PloS one.

[68]  John Calvin Reed,et al.  Mechanism of Bcl-2 and Bcl-XL inhibition of NLRP1 inflammasome: Loop domain-dependent suppression of ATP binding and oligomerization , 2009, Proceedings of the National Academy of Sciences.

[69]  L. Joosten,et al.  Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. , 2009, Blood.

[70]  B. Lie,et al.  A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes , 2009, Genes and Immunity.

[71]  G. Núñez,et al.  The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis , 2009, Nature Immunology.

[72]  Sunny Shin,et al.  Asc and Ipaf Inflammasomes Direct Distinct Pathways for Caspase-1 Activation in Response to Legionella pneumophila , 2009, Infection and Immunity.

[73]  B. Cookson,et al.  Pyroptosis: host cell death and inflammation , 2009, Nature Reviews Microbiology.

[74]  Jonathan D. G. Jones,et al.  The TIR domain of TIR-NB-LRR resistance proteins is a signaling domain involved in cell death induction. , 2009, Molecular plant-microbe interactions : MPMI.

[75]  D. Gumucio,et al.  Pyrin and ASC Co-Localize to Cellular Sites that Are Rich in Polymerizing Actin , 2009, Experimental biology and medicine.

[76]  S. Akira,et al.  Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production , 2008, Nature.

[77]  K. Rock,et al.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.

[78]  F. Meissner,et al.  Superoxide dismutase 1 regulates caspase-1 and endotoxic shock , 2008, Nature Immunology.

[79]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[80]  F. Sutterwala,et al.  Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome , 2007, The Journal of experimental medicine.

[81]  M. Salkinoja-Salonen,et al.  Bafilomycin A1 is a potassium ionophore that impairs mitochondrial functions , 2007, Journal of bioenergetics and biomembranes.

[82]  F. Martinon,et al.  Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration , 2007, Cell Death and Differentiation.

[83]  C. Sasakawa,et al.  Differential Regulation of Caspase-1 Activation, Pyroptosis, and Autophagy via Ipaf and ASC in Shigella-Infected Macrophages , 2007, PLoS pathogens.

[84]  G. Dubyak,et al.  Differential Requirement of P2X7 Receptor and Intracellular K+ for Caspase-1 Activation Induced by Intracellular and Extracellular Bacteria* , 2007, Journal of Biological Chemistry.

[85]  E. Alnemri,et al.  The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation , 2007, Cell Death and Differentiation.

[86]  D. Monack,et al.  Type I interferon signaling is required for activation of the inflammasome during Francisella infection , 2007, The Journal of experimental medicine.

[87]  A. Osterman,et al.  Bcl-2 and Bcl-XL Regulate Proinflammatory Caspase-1 Activation by Interaction with NALP1 , 2007, Cell.

[88]  Sheri L. Riccardi,et al.  NALP1 in vitiligo-associated multiple autoimmune disease. , 2007, The New England journal of medicine.

[89]  J. Harton,et al.  Pyrin-Only Protein 2 Modulates NF-κB and Disrupts ASC:CLR Interactions , 2007, The Journal of Immunology.

[90]  N. Volkmann,et al.  Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. , 2007, Molecular cell.

[91]  Y. Rojanasakul,et al.  Cellular Pyrin Domain-Only Protein 2 Is a Candidate Regulator of Inflammasome Activation , 2006, Infection and Immunity.

[92]  B. Cookson,et al.  Caspase‐1‐dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages , 2006, Cellular microbiology.

[93]  M. Exline,et al.  Caspase-1 regulates Escherichia coli sepsis and splenic B cell apoptosis independently of interleukin-1beta and interleukin-18. , 2006, American journal of respiratory and critical care medicine.

[94]  J. Tschopp,et al.  Caspase-1 Activation of Lipid Metabolic Pathways in Response to Bacterial Pore-Forming Toxins Promotes Cell Survival , 2006, Cell.

[95]  Alan Aderem,et al.  Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf , 2006, Nature Immunology.

[96]  J. Bertin,et al.  Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages , 2006, Nature Immunology.

[97]  W. Dietrich,et al.  Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin , 2006, Nature Genetics.

[98]  G. McFadden,et al.  A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. , 2005, Immunity.

[99]  S. Leppla,et al.  Bacillus anthracis lethal toxin induces TNF-α–independent hypoxia-mediated toxicity in mice , 2003 .

[100]  A. Godzik,et al.  The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation. , 2003, The Biochemical journal.

[101]  Peter Schotte,et al.  Caspase-11 Gene Expression in Response to Lipopolysaccharide and Interferon-γ Requires Nuclear Factor-κB and Signal Transducer and Activator of Transcription (STAT) 1* , 2002, The Journal of Biological Chemistry.

[102]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[103]  D. Kastner,et al.  The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. , 2001, Blood.

[104]  M. Antonelli,et al.  Sepsis and septic shock: pro-inflammatory or anti-inflammatory state? , 1999, Journal of chemotherapy.

[105]  M. Torrisi,et al.  The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. , 1999, Molecular biology of the cell.

[106]  Junying Yuan,et al.  Murine Caspase-11, an ICE-Interacting Protease, Is Essential for the Activation of ICE , 1998, Cell.

[107]  D. Ferrari,et al.  ATP-mediated cytotoxicity in microglial cells , 1997, Neuropharmacology.

[108]  F. Di Virgilio,et al.  Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. , 1997, Journal of immunology.

[109]  L. Old,et al.  Characterization of tumor necrosis factor-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[110]  D. Ferrari,et al.  Purinergic Modulation of Interleukin-1β Release from Microglial Cells Stimulated with Bacterial Endotoxin , 1997, The Journal of experimental medicine.

[111]  G. Fantuzzi,et al.  Effect of endotoxin in IL-1 beta-deficient mice. , 1996, Journal of immunology.

[112]  D. Vaux,et al.  Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[113]  R. Sundler,et al.  Bafilomycin A1 inhibits lysosomal, phagosomal, and plasma membrane H+‐ATPase and induces lysosomal enzyme secretion in macrophages , 1995, Journal of cellular physiology.

[114]  R. Kamen,et al.  Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock , 1995, Cell.

[115]  J. Dangl,et al.  Arabidopsis mutants simulating disease resistance response , 1994, Cell.

[116]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[117]  Y. S. Sathe,et al.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. , 1966, Annals of internal medicine.

[118]  Julia Romanova,et al.  Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. , 2005, The Journal of general virology.